WEDNESDAY, June 26, 2024 -- For patients with obesity-related heart failure with preserved ejection fraction (HFpEF), semaglutide reduces body weight...

WEDNESDAY, July 3, 2024 -- Trendy weight-loss drugs appear to increase the risk of a rare and potentially blinding eye condition, a new study...

TUESDAY, July 2, 2024 -- Cutting-edge weight-loss drugs like Wegovy and Ozempic can help treat alcoholism, a new study says. People taking semaglutide...

The manufacturers of the most popular weight loss drugs are being challenged in court.

CNN  —  People who take Ozempic or Wegovy may have a higher risk of developing a rare form of blindness, a new study suggests. Still, doctors say...

The hype is enormous: A new weight-loss drug is being aggressively marketed on social media – promising patients a quick fix for obesity. But...

There are no current treatments for non-arteritic anterior ischemic optic neuropathy (NAION) and vision often does not improve.

Weight loss jabs Ozempic and Wegovy could raise the risk of going blind, research suggests.

Medications to treat type-2 diabetes such as Ozempic and Semaglutide have a secondary use as rapid weight loss medications. It is so popular among...

New research showed that tirzepatide, the compound in Zepbound, improved symptoms of obstructive sleep apnea.